Nasdaq

QIAGEN Launches QIAsymphony SP Device Outside the U.S.

Molecular diagnostics major QIAGEN N.V.QGEN recently announced the launch of QIAsymphony SP instrument as a front-end option for sample processing for its GeneReader NGS System outside the U.S. The ...
technologynetworks

QIAGEN Introduces Two new Solutions for Automated Sample Purification

QIAGEN has announced the introduction of QIAsymphony SP, a purification system that offers medium- to high-throughput laboratories a combination of a broad application range and flexible processing ...
Business Wire

QIAGEN Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced the 2,500th placement of QIAsymphony, the leading Sample to Insight workflow ...
Medindia

QIAGEN Seeks U.S. Regulatory Clearance for Full QIAsymphony RGQ MDx Workflow and Announces Submission of First Assay of its HAI Portfolio

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced plans to roll out a portfolio of assays for the QIAsymphony platform to aid in the diagnosis of healthcare-associated ...
Investing

QIAGEN Launches QIAsymphony SP Device Outside The U.S.

Molecular diagnostics major QIAGEN N.V. (NASDAQ:QGEN) recently announced the launch of QIAsymphony SP instrument as a front-end option for sample processing for its GeneReader NGS System outside the U ...